Azeta Pharma GmbH is a specialised pharmaceutical boutique based in Germany. We help companies identify, evaluate and develop business opportunities across markets and partnerships — with a particular focus on connecting European and international markets, including Europe and India.
We work with pharmaceutical and life sciences companies on selected business development, strategic, market-entry, partnership and cross-border initiatives.
Our clients engage us where commercial understanding of the industry, sector knowledge and access to relevant international networks matter — typically alongside their own management team rather than in place of it.
Engagements are deliberately limited in number. That allows us to stay close to each mandate, communicate directly, and remain flexible as circumstances change.
About Azeta PharmaMost mandates begin with a single commercial question and end with an agreement, an introduction that leads somewhere, or a clear reason not to proceed.
Taking a defined commercial opportunity from an initial idea to concrete discussions with relevant counterparties.
An outside commercial perspective on markets, portfolios and partnership questions.
Practical groundwork for companies considering a new market or broader international presence.
Identifying and qualifying partners, with a particular focus on Europe and India/Asia in both directions.
A significant part of our work involves companies on two sides of a border: European firms looking towards India and Asia for supply, products or partners, and Indian and Asian companies building a commercial presence in Europe.
This includes identifying potential partners, evaluating business opportunities, supporting market-entry discussions, facilitating introductions and accompanying business development initiatives through to implementation.
Our international perspectiveThe commercial question behind the request, what has been tried, and which constraints are fixed.
Which markets, opportunities and counterparties are genuinely worth pursuing — and which are not.
A short, concrete plan with a realistic sequence, timeline and expected outcome.
Approaches, discussions, negotiation support and follow-up, alongside the client's team.
Short, factual observations from the mandates and markets we are currently working in. No commentary for its own sake.
We are seeing sustained interest from Indian manufacturers in structured European market entry — increasingly with a preference for partnership models over own-entity setups.
Counterparties are opening partnership discussions earlier, before regulatory milestones are complete. This changes how opportunities should be prepared and presented.
Several clients are reassessing existing distribution arrangements in Germany and neighbouring markets, with a focus on channel coverage rather than pricing alone.
A short email a few times a year on market developments, partnership trends and Europe–India business development. No marketing sequences.
We use your address only to send these updates. You can ask us to remove it at any time. See our privacy notice.
If you are considering a partnership, a new market or a business development initiative, we are glad to have an initial, confidential conversation about whether we are the right counterpart for it.